Long noncoding RNA NONHSAT177112.1 aggravates inflammation and apoptosis in LPS-treated human cardiomyocytes

Epigenomics. 2021 Mar;13(6):411-422. doi: 10.2217/epi-2020-0345. Epub 2021 Mar 1.

Abstract

Aim: To explore the roles of lncRNA NONHSAT177112.1 in the inflammatory injury of human cardiomyocytes (HCMs) induced by lipopolysaccharide (LPS). Materials & methods: The sublocalization of NONHSAT177112.1 was detected by FISH. HCMs were stimulated with LPS to induce inflammatory injury. NONHSAT177112.1 expression was detected by quantitative real-time PCR. Cell apoptosis and viability were detected by flow cytometry and CCK-8 assays. The expression of inflammatory cytokines and myocardial enzymes were detected by PCR and ELISA. Results: NONHSAT177112.1 is expressed in the nucleus and cytoplasm. NONHSAT177112.1 showed dynamic expression that first increased and then decreased during LPS stimulation. NONHSAT177112.1 knockdown reversed the promotion effect of LPS on inflammatory injury. Conversely, NONHSAT177112.1 overexpression exerted the opposite effects. Conclusion: NONHSAT177112.1 aggravates inflammatory injury in LPS-treated HCMs.

Keywords: NONHSAT177112.1; human cardiomyocytes; lipopolysaccharide; long noncoding RNA; myocarditis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis*
  • Cell Survival
  • Cells, Cultured
  • Humans
  • Inflammation / etiology
  • Inflammation / metabolism
  • Inflammation / pathology*
  • Lipopolysaccharides / adverse effects*
  • MicroRNAs / genetics
  • Myocytes, Cardiac / immunology
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / pathology*
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • RNA, Long Noncoding / genetics*
  • Signal Transduction

Substances

  • Lipopolysaccharides
  • MicroRNAs
  • NF-kappa B
  • RNA, Long Noncoding